Skip to main content
Clinical Trials/NL-OMON44292
NL-OMON44292
Completed
Not Applicable

Innovative MRI techniques to improve treatment stratification of patients with Esophageal cancer: an optimization and pilot study - IMPROVE

Academisch Medisch Centrum0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Esophageal cancer
Sponsor
Academisch Medisch Centrum
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Volunteers:
  • Written informed consent.;Patients:
  • Patients with biopsy proven esophageal cancer (squamous cell carcinoma or adenocarcinoma).
  • Suspected nodal involvement on EUS or CT at diagnosis.
  • WHO\-performance score 0\-2\.
  • Scheduled for surgery.
  • Written informed consent.

Exclusion Criteria

  • Any psychological, familial, sociological or geographical condition potentially hampering adequate informed consent or compliance with the study protocol.
  • Contra\-indications for MR scanning, including patients with a pacemaker, cochlear implant or neurostimulator; patients with non\-MR compatible metallic implants in their eye, spine, thorax or abdomen; or a non\-MR compatible aneurysm clip in their brain; patients with severe claustrophobia.
  • Active inflammatory diseases
  • History of anaphylaxis or other hypersensitivity reactions
  • History of iron overload
  • History of abnormal liver function, or elevated liver enzymes (ALAT, ASAT \> 3 times upper limit of normal)
  • Elevated Serum Transferrin Saturation (TSAT) (\>50%) or hemoglobin (\>10\.5mmol/L)
  • Deminished kidney function (eGFR\<60\)

Outcomes

Primary Outcomes

Not specified

Similar Trials